These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3552516)

  • 1. Effects of relaxation therapy on patients with type I diabetes mellitus.
    Feinglos MN; Hastedt P; Surwit RS
    Diabetes Care; 1987; 10(1):72-5. PubMed ID: 3552516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal blood glucose control in type I diabetes mellitus.
    Bolli GB; Perriello G; Fanelli CG; De Feo P
    Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled study of biofeedback-assisted relaxation in type I diabetes.
    McGrady A; Bailey BK; Good MP
    Diabetes Care; 1991 May; 14(5):360-5. PubMed ID: 2060447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of biofeedback assisted relaxation training on blood glucose levels in a type I insulin dependent diabetic. A case report.
    McGrady A; Gerstenmaier L
    J Behav Ther Exp Psychiatry; 1990 Mar; 21(1):69-75. PubMed ID: 2197298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of EMG biofeedback on diabetes.
    Seeburg KN; DeBoer KF
    Biofeedback Self Regul; 1980 Jun; 5(2):289-93. PubMed ID: 6994826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mood in outcome of biofeedback assisted relaxation therapy in insulin dependent diabetes mellitus.
    McGrady A; Horner J
    Appl Psychophysiol Biofeedback; 1999 Mar; 24(1):79-88. PubMed ID: 10553485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an EMG biofeedback relaxation program on the control of diabetes: a case study.
    Fowler JE; Budzynski TH; VandenBergh RL
    Biofeedback Self Regul; 1976 Mar; 1(1):105-12. PubMed ID: 791380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxation training for NIDDM. Predicting who may benefit.
    Lane JD; McCaskill CC; Ross SL; Feinglos MN; Surwit RS
    Diabetes Care; 1993 Aug; 16(8):1087-94. PubMed ID: 8375238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
    Amiel SA; Sherwin RS; Simonson DC; Tamborlane WV
    Diabetes; 1988 Jul; 37(7):901-7. PubMed ID: 3290007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of muscular exercise and metabolic control on cortisol, growth hormone, plasma-epinephrine and plasma-norepinephrine in type-I diabetics [author's transl)].
    Mühlhauser I; Schernthaner G; Seebacher C; Templ H; Ukponmwan O
    Acta Med Austriaca; 1981; 8(2):48-53. PubMed ID: 7025547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of nocturnal hypoglycemia to cause fasting hyperglycemia in patients with insulin-dependent diabetes mellitus.
    Tordjman KM; Havlin CE; Levandoski LA; White NH; Santiago JV; Cryer PE
    N Engl J Med; 1987 Dec; 317(25):1552-9. PubMed ID: 3317053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term improvement in glycemic control utilizing continuous subcutaneous insulin infusion: the effect on 24-hour integrated concentrations of counterregulatory hormones and plasma lipids in insulin-dependent diabetes mellitus.
    Hershcopf R; Plotnick LP; Kaya K; Benedict GW; Hadji-Georgopoulos A; Margolis S; Kowarski AA
    J Clin Endocrinol Metab; 1982 Mar; 54(3):504-9. PubMed ID: 7035481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biofeedback-assisted stress management for insulin-treated diabetes mellitus.
    Rosenbaum L
    Biofeedback Self Regul; 1983 Dec; 8(4):519-32. PubMed ID: 6372874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes.
    Amiel SA; Heller SR; Macdonald IA; Schwartz SL; Klaff LJ; Ruggles JA; Weyer C; Kolterman OG; Maggs DG
    Diabetes Obes Metab; 2005 Sep; 7(5):504-16. PubMed ID: 16050943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.
    Holstein A; Hammer C; Plaschke A; Ptak M; Kuhn J; Diekmann J; Kleesiek K; Egberts EH
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):429-34. PubMed ID: 15372362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus.
    Weinger K; Jacobson AM; Draelos MT; Finkelstein DM; Simonson DC
    Am J Med; 1995 Jan; 98(1):22-31. PubMed ID: 7825615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofeedback-assisted relaxation in type 2 diabetes.
    McGinnis RA; McGrady A; Cox SA; Grower-Dowling KA
    Diabetes Care; 2005 Sep; 28(9):2145-9. PubMed ID: 16123481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of relaxation training on glucose tolerance and diabetic control in type II diabetes.
    Jablon SL; Naliboff BD; Gilmore SL; Rosenthal MJ
    Appl Psychophysiol Biofeedback; 1997 Sep; 22(3):155-69. PubMed ID: 9428966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetics. A mechanism for diabetic instability.
    Shamoon H; Hendler R; Sherwin RS
    Diabetes; 1980 Apr; 29(4):284-91. PubMed ID: 6987117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.